Alterations of lipid metabolism provide serologic biomarkers for the detection of asymptomatic versus symptomatic COVID-19 patients

COVID-19 pandemic exerts a health care emergency around the world. The illness severity is heterogeneous. It is mostly unknown why some individuals who are positive for SARS-CoV-2 antibodies stay asymptomatic while others show moderate to severe disease symptoms. Reliable biomarkers for early detect...

Descripción completa

Detalles Bibliográficos
Autores principales: Janneh, Alhaji H., Kassir, Mohamed Faisal, Dwyer, Connor J., Chakraborty, Paramita, Pierce, Jason S., Flume, Patrick A., Li, Hong, Nadig, Satish N., Mehrotra, Shikhar, Ogretmen, Besim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270895/
https://www.ncbi.nlm.nih.gov/pubmed/34244584
http://dx.doi.org/10.1038/s41598-021-93857-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270895/
https://www.ncbi.nlm.nih.gov/pubmed/34244584
http://dx.doi.org/10.1038/s41598-021-93857-7

Ejemplares similares